A detailed history of Mariner, LLC transactions in Evotec Se stock. As of the latest transaction made, Mariner, LLC holds 10,500 shares of EVO stock, worth $44,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,500
Previous 13,614 22.87%
Holding current value
$44,310
Previous $49,000 12.24%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$2.91 - $5.55 $9,061 - $17,282
-3,114 Reduced 22.87%
10,500 $43,000
Q3 2024

Nov 13, 2024

BUY
$2.96 - $5.34 $3,856 - $6,958
1,303 Added 10.58%
13,614 $49,000
Q2 2024

Aug 13, 2024

BUY
$4.07 - $7.87 $50,105 - $96,887
12,311 New
12,311 $59,000

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.49B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.